Non-invasive prenatal diagnosis for homozygous α0-thalassemia based on paternal different SNP with allele-specific real-time fluorescence PCR: establishment and application
|更新时间:2026-01-09
|
Non-invasive prenatal diagnosis for homozygous α0-thalassemia based on paternal different SNP with allele-specific real-time fluorescence PCR: establishment and application
Journal of Army Medical UniversityVol. 34, Issue 20, Pages: 2082-2085(2012)
Liu Yanhui,Wu Yamin,Shi Shaoquan,Lou Jiwu,Ma Qiulin,He Yi,Xu Wanfang,Lin Yangyang,Zhou Wanjun.Non-invasive prenatal diagnosis for homozygous α0-thalassemia based on paternal different SNP with allele-specific real-time fluorescence PCR: establishment and application[J].J Amry Med Univ (J Third Mil Med Univ),2012,34(20):2082-2085.
Liu Yanhui,Wu Yamin,Shi Shaoquan,Lou Jiwu,Ma Qiulin,He Yi,Xu Wanfang,Lin Yangyang,Zhou Wanjun.Non-invasive prenatal diagnosis for homozygous α0-thalassemia based on paternal different SNP with allele-specific real-time fluorescence PCR: establishment and application[J].J Amry Med Univ (J Third Mil Med Univ),2012,34(20):2082-2085.DOI:
Non-invasive prenatal diagnosis for homozygous α0-thalassemia based on paternal different SNP with allele-specific real-time fluorescence PCR: establishment and application
Objective To establish and evaluate an allele-specific real-time fluorescence PCR (AS-qPCR) assay for non-invasive exclusive prenatal diagnosis of homozygous α
0
-thalassemia. Methods Among 9 SNPs within the SEA deletion range
the different SNPs between parents were determined with PCR micro-sequencing technology. The paternal SNP was detected in maternal plasma DNA with AS-qPCR to determine whether the paternal normal haplotype had been inherited to the fetus. Results Among 167 families
160 were found to have one or
more parents-different SNPs with the detection rates over 98.16%. The paternal normal SNPs were detected in 94 maternal plasma DNA. In this way
they avoided invasive prenatal diagnosis with a detection rate of 57.67%. These results were 100% coincidence with the results of CVS or amniocentesis. Conclusion Using AS-qPCR to detect the parents-difference SNPs in maternal plasma DNA in the early stage of gestation
is a non-invasive exclusive prenatal diagnosis of homozygous α
0
-thalassemia. This method can make about 50% high-risk pregnant women to avoid invasive prenatal diagnosis.